BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 21083159)

  • 1. Current technologies and considerations for drug bioanalysis in oral fluid.
    Gallardo E; Barroso M; Queiroz JA
    Bioanalysis; 2009 Jun; 1(3):637-67. PubMed ID: 21083159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analytical techniques for drug detection in oral fluid.
    Lillsunde P
    Ther Drug Monit; 2008 Apr; 30(2):181-7. PubMed ID: 18367978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drugs of abuse in oral fluid collected by two different sample kits--stability testing and validation using ultra performance tandem mass spectrometry analysis.
    Lund HM; Øiestad EL; Gjerde H; Christophersen AS
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Nov; 879(30):3367-77. PubMed ID: 21962269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current developments in drug testing in oral fluid.
    Pil K; Verstraete A
    Ther Drug Monit; 2008 Apr; 30(2):196-202. PubMed ID: 18367980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioanalytical methods for the determination of cocaine and metabolites in human biological samples.
    Barroso M; Gallardo E; Queiroz JA
    Bioanalysis; 2009 Aug; 1(5):977-1000. PubMed ID: 21083066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laboratory evaluation and field application of roadside oral fluid collectors and drug testing devices.
    Crouch DJ; Walsh JM; Cangianelli L; Quintela O
    Ther Drug Monit; 2008 Apr; 30(2):188-95. PubMed ID: 18367979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Confirmation by LC-MS of drugs in oral fluid obtained from roadside testing.
    Concheiro M; de Castro A; Quintela O; Cruz A; López-Rivadulla M
    Forensic Sci Int; 2007 Aug; 170(2-3):156-62. PubMed ID: 17658709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of driving with blood drug concentrations above proposed new legal limits in Norway: estimations based on drug concentrations in oral fluid.
    Gjerde H; Normann PT; Christophersen AS; Mørland J
    Forensic Sci Int; 2011 Jul; 210(1-3):221-7. PubMed ID: 21482055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of cannabis in oral fluid specimens by GC-MS with automatic SPE.
    Choi H; Baeck S; Kim E; Lee S; Jang M; Lee J; Choi H; Chung H
    Sci Justice; 2009 Dec; 49(4):242-6. PubMed ID: 20120601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A rapid and sensitive method for the identification of delta-9-tetrahydrocannabinol in oral fluid by liquid chromatography-tandem mass spectrometry.
    Molnar A; Lewis J; Doble P; Hansen G; Prolov T; Fu S
    Forensic Sci Int; 2012 Feb; 215(1-3):92-6. PubMed ID: 21367546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Replacement of immunoassay by LC tandem mass spectrometry for the routine measurement of drugs of abuse in oral fluid.
    Allen KR; Azad R; Field HP; Blake DK
    Ann Clin Biochem; 2005 Jul; 42(Pt 4):277-84. PubMed ID: 15989728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drugs in oral fluid Part I. Validation of an analytical procedure for licit and illicit drugs in oral fluid.
    Wylie FM; Torrance H; Anderson RA; Oliver JS
    Forensic Sci Int; 2005 Jun; 150(2-3):191-8. PubMed ID: 15944059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roadside oral fluid testing: comparison of the results of drugwipe 5 and drugwipe benzodiazepines on-site tests with laboratory confirmation results of oral fluid and whole blood.
    Pehrsson A; Gunnar T; Engblom C; Seppä H; Jama A; Lillsunde P
    Forensic Sci Int; 2008 Mar; 175(2-3):140-8. PubMed ID: 17640837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance characteristics of the Cozart RapiScan Oral Fluid Drug Testing System for opiates in comparison to ELISA and GC/MS following controlled codeine administration.
    Kacinko SL; Barnes AJ; Kim I; Moolchan ET; Wilson L; Cooper GA; Reid C; Baldwin D; Hand CW; Huestis MA
    Forensic Sci Int; 2004 Apr; 141(1):41-8. PubMed ID: 15066713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between oral fluid and blood concentrations of drugs of abuse in drivers suspected of driving under the influence of drugs.
    Wille SM; Raes E; Lillsunde P; Gunnar T; Laloup M; Samyn N; Christophersen AS; Moeller MR; Hammer KP; Verstraete AG
    Ther Drug Monit; 2009 Aug; 31(4):511-9. PubMed ID: 19571773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bio-analysis of forensically relevant drugs in alternative matrices by liquid chromatography-tandem mass spectrometry.
    Laloup M; Samyn N; Maes V
    Verh K Acad Geneeskd Belg; 2008; 70(5-6):347-67. PubMed ID: 19725394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Driving under the influence of drugs -- evaluation of analytical data of drugs in oral fluid, serum and urine, and correlation with impairment symptoms.
    Toennes SW; Kauert GF; Steinmeyer S; Moeller MR
    Forensic Sci Int; 2005 Sep; 152(2-3):149-55. PubMed ID: 15978340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Introduction and review of collection techniques and applications of drug testing of oral fluid.
    Drummer OH
    Ther Drug Monit; 2008 Apr; 30(2):203-6. PubMed ID: 18367981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug analytics in oral fluid using immunoassay].
    Dierich O; Soyka M
    Fortschr Neurol Psychiatr; 2005 Jul; 73(7):401-8. PubMed ID: 16012919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for drugs of abuse: which matrix, oral fluid or urine?
    Allen KR
    Ann Clin Biochem; 2011 Nov; 48(Pt 6):531-41. PubMed ID: 21885472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.